Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Vaccines and Antiviral Agents

Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus Infections

B. M. Krenn, E. Gaudernak, B. Holzer, K. Lanke, F. J. M. Van Kuppeveld, J. Seipelt
B. M. Krenn
1Max F. Perutz Laboratories, Medical University of Vienna, Dr. Bohr-Gasse 9/3, 1030 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Gaudernak
1Max F. Perutz Laboratories, Medical University of Vienna, Dr. Bohr-Gasse 9/3, 1030 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Holzer
1Max F. Perutz Laboratories, Medical University of Vienna, Dr. Bohr-Gasse 9/3, 1030 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Lanke
2Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, 6500 HB Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. J. M. Van Kuppeveld
2Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, 6500 HB Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Seipelt
1Max F. Perutz Laboratories, Medical University of Vienna, Dr. Bohr-Gasse 9/3, 1030 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joachim.seipelt@meduniwien.ac.at
DOI: 10.1128/JVI.01543-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    PT and HK dramatically reduce picornavirus multiplication and increase cell viability. Viral titers of HRV2-infected HeLa cells (MOI = 20) in the presence or absence of indicated concentrations of PT (A) or HK plus 30 mM MgCl2 (B) were determined 24 h p.i. Results for one representative experiment of three experiments are shown. HeLa cells were infected with HRV2 (MOI = 50) or mock infected, and different concentrations of PT (C) or HK-MgCl2 (D) were added. At 24 h p.i., a CellTiter 96 AQueous nonradioactive cell proliferation assay was performed according to the manufacturer's protocol. Extinction at 492 nm reflects cell viability. The means ± standard deviations of quintuples obtained in one representative experiment of three performed are shown. (E) HeLa cells were infected with CVB3 or mengovirus (MOI = 10) and incubated with 10 μM PT or 75 μM HK-30 mM MgCl2, respectively. Virus production of infected cells was determined by TCID50 assay at 24 h p.i. The results for one of two representative experiments are shown. −, control.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    PT and HK abolish HRV2-triggered eIF4GI cleavage and affect viral polyprotein processing. (A) HRV2-infected HeLa cells (MOI = 20) were either mock treated or treated with 10 μM PT or 125 μM HK-30 mM MgCl2. After the indicated time points, protein extracts were collected and analyzed by Western blotting using an antibody specific for eIF4GI and its cleavage products. (B) HeLa cells were preincubated with 10 μM PT or 125 μM HK-30 mM MgCl2 for 30 min and infected with HRV2 (MOI = 50) in the presence of the substances. At 6 h p.i., newly synthesized proteins were labeled with [32S]Met/Cys for 1 hour. At the indicated time points, VP2 or VP2-containing precursor proteins were isolated by immunoprecipitation and analyzed by SDS-PAGE and autoradiography. Immunoprecipitation of mock-infected labeled cells did not show any signal. MW, molecular weight in thousands.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    PT and HK abrogate 3D and 3C processing of CVB3. HeLa cells infected with coxsackievirus B3 (MOI = 50) were incubated with 125 μM PDTC, 75 μM HK-30 mM MgCl2, or 10 μM PT in the presence or absence of 10 μM TPEN. At 5 h p.i., cells were starved half an hour prior to 1 h of labeling with [35S]Met/Cys. Harvested cell lysates were subjected to immunoprecipitation using either antibodies specific for 3D (left panel) or 3C (right panel) and then analyzed by SDS-PAGE and autoradiography. Results for a representative experiment are shown. −, TPEN absent; +, TPEN present.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Zinc ions are responsible for the antiviral property of PT and HK. HeLa cells were infected with HRV2 (MOI = 20) (A), CVB3 (MOI = 10) (B), or mengovirus (MOI = 10) (C) and incubated with 10 μM EDTA or 10 μM of Zn-EDTA, Ca-EDTA, and Mg-EDTA, respectively. If indicated, 10 μM PT (A, B, and C), 125 μM HK-30 mM MgCl2 (A), or 75 μM HK-MgCl2 (B and C) was added at the time of infection. The virus titers in the supernatants of the infected cells were determined by a TCID50 assay at 24 h p.i. and shown as log TCID50/ml. Viral infection without addition of compounds is labeled as “cont.” The results for one representative experiment of three are shown.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    PDTC, PT, and HK cause import of extracellular 65Zn2+ levels in a dose-dependent manner. (A) HeLa cells in serum-free culture medium were incubated with 5 μM 65Zn2+ and 125 μM PDTC, 10 μM PT, or 125 μM HK-30 mM MgCl2. At the indicated time points, the cells were harvested and washed with a buffer containing EDTA, and the amount of intracellular 65Zn2+ was determined in a Packard Cobra II γ-counter. Statistical variations between different samples are determined to be a maximal ±10% (data not shown). The results for one of three experiments are shown. (B) HeLa cells in serum-free culture medium were incubated with 5 μM 65Zn2+ and various concentrations of PDTC (top panel), PT (middle panel), or HK-MgCl2 (lower panel) for 15 min. Then, the cells were collected and washed, and the amount of intracellular 65Zn2+ was determined as described above. The results for one of five experiments are shown.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Zinc ionophores influence the labile Zn2+ pool. HeLa cells were loaded with 5 μM FluoZin-3 (A) or 1 μM RhodZin-3 (B) in PBS for 15 min at 37°C. After extensive washing and 1 h of de-esterification in medium, zinc uptake was induced by treatment with 125 μM PDTC, 10 μM PT, and 125 μM HK-30 mM MgCl2 in growth medium. If indicated, after 30 min of chemical treatment, ionophores were removed for 1 hour (PDTC + 1 h removal, PT + 1 h removal, HK + 1 h removal). Pictures were taken at the indicated time points by live fluorescence microscopy with 60× optics. Examples of images of three independent experiments were chosen.

PreviousNext
Back to top
Download PDF
Citation Tools
Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus Infections
B. M. Krenn, E. Gaudernak, B. Holzer, K. Lanke, F. J. M. Van Kuppeveld, J. Seipelt
Journal of Virology Dec 2008, 83 (1) 58-64; DOI: 10.1128/JVI.01543-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus Infections
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus Infections
B. M. Krenn, E. Gaudernak, B. Holzer, K. Lanke, F. J. M. Van Kuppeveld, J. Seipelt
Journal of Virology Dec 2008, 83 (1) 58-64; DOI: 10.1128/JVI.01543-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS AND DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antiviral agents
enterovirus
Mengovirus
Monoterpenes
Pyridines
rhinovirus
Thiones
Tropolone

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514